Search results

Articles (6)

Journals (0)

1-6 of 6 results for IL-23 p19 subunit

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published 2026

Efficacy and safety of risankizumab in moderate-to-severe Crohn’s disease: a systematic review and meta-analysis

Hafsa Nasim, Abdul Hannan Siddiqui, Syed Jawad Khan [...]

Therapeutic Advances in Gastroenterology

Retricted accessReview articleFirst published April, 2019

Tildrakizumab: A Review of Phase II and III Clinical Trials

Sree S. Kolli, Sarah D. Gabros, Adrian Pona [...]

Annals of Pharmacotherapy

Retricted accessResearch articleFirst published August, 2019

The rs2066808 Polymorphism Located Near the IL-23A Gene Is Associated with Premature Coronary Artery Disease in Mexican Population (GEA Study)

Christian Vázquez-Vázquez, Rosalinda Posadas-Sánchez, Nonanzit Pérez-Hernández [...]

DNA and Cell Biology

Retricted accessResearch articleFirst published June, 2002

Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity

B R Lauwerys, J Van Snick, F A Houssiau

Lupus

Retricted accessResearch articleFirst published September, 2023

The Effectiveness of Risankizumab Following Guselkumab Failure in Moderate-to-Severe Psoriasis Patients: A Retrospective Study

Camille Hamm, Nusha Ramsoondar, Michaela McGillis [...]

Journal of Cutaneous Medicine and Surgery

Open accessResearch articleFirst published 2025

Clinical insights into IL-23 inhibition: risankizumab for Crohn’s disease through a systematic review and meta-analysis of randomized controlled trials

Po-Feng Huang, Tien-Yu Huang, Yi-Chiao Cheng [...]

Therapeutic Advances in Gastroenterology

Search results

Articles (6)

Journals (0)

1-6 of 6 results for IL-23 p19 subunit

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published 2026

Efficacy and safety of risankizumab in moderate-to-severe Crohn’s disease: a systematic review and meta-analysis

Hafsa Nasim, Abdul Hannan Siddiqui, Syed Jawad Khan [...]

Therapeutic Advances in Gastroenterology

Retricted accessReview articleFirst published April, 2019

Tildrakizumab: A Review of Phase II and III Clinical Trials

Sree S. Kolli, Sarah D. Gabros, Adrian Pona [...]

Annals of Pharmacotherapy

Retricted accessResearch articleFirst published August, 2019

The rs2066808 Polymorphism Located Near the IL-23A Gene Is Associated with Premature Coronary Artery Disease in Mexican Population (GEA Study)

Christian Vázquez-Vázquez, Rosalinda Posadas-Sánchez, Nonanzit Pérez-Hernández [...]

DNA and Cell Biology

Retricted accessResearch articleFirst published June, 2002

Serum IL-12 in systemic lupus erythematosus: absence of p70 heterodimers but presence of p40 monomers correlating with disease activity

B R Lauwerys, J Van Snick, F A Houssiau

Lupus

Retricted accessResearch articleFirst published September, 2023

The Effectiveness of Risankizumab Following Guselkumab Failure in Moderate-to-Severe Psoriasis Patients: A Retrospective Study

Camille Hamm, Nusha Ramsoondar, Michaela McGillis [...]

Journal of Cutaneous Medicine and Surgery

Open accessResearch articleFirst published 2025

Clinical insights into IL-23 inhibition: risankizumab for Crohn’s disease through a systematic review and meta-analysis of randomized controlled trials

Po-Feng Huang, Tien-Yu Huang, Yi-Chiao Cheng [...]

Therapeutic Advances in Gastroenterology